Concepts (356)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking | 104 | 2020 | 823 | 15.300 |
Why?
|
| Tobacco Use Disorder | 74 | 2020 | 242 | 14.180 |
Why?
|
| Adolescent Behavior | 51 | 2020 | 185 | 6.560 |
Why?
|
| Smoking Prevention | 37 | 2018 | 158 | 5.130 |
Why?
|
| Substance Withdrawal Syndrome | 18 | 2016 | 119 | 4.400 |
Why?
|
| Behavior, Addictive | 20 | 2020 | 72 | 3.990 |
Why?
|
| Commerce | 19 | 2020 | 53 | 3.850 |
Why?
|
| Personal Autonomy | 17 | 2015 | 68 | 3.780 |
Why?
|
| Adolescent | 116 | 2020 | 5816 | 3.240 |
Why?
|
| Nicotine | 19 | 2017 | 112 | 3.220 |
Why?
|
| Tobacco Products | 10 | 2020 | 71 | 3.000 |
Why?
|
| Smoking Cessation | 31 | 2020 | 540 | 2.680 |
Why?
|
| Tobacco Industry | 13 | 2014 | 19 | 2.520 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2016 | 57 | 1.850 |
Why?
|
| Minors | 6 | 2020 | 8 | 1.810 |
Why?
|
| Male | 96 | 2020 | 27623 | 1.410 |
Why?
|
| Female | 95 | 2020 | 30613 | 1.320 |
Why?
|
| Humans | 140 | 2020 | 59106 | 1.300 |
Why?
|
| Child | 42 | 2016 | 4168 | 1.220 |
Why?
|
| Psychometrics | 17 | 2016 | 362 | 1.210 |
Why?
|
| Students | 7 | 2016 | 202 | 1.000 |
Why?
|
| Surveys and Questionnaires | 20 | 2018 | 2509 | 1.000 |
Why?
|
| Craving | 5 | 2016 | 35 | 0.990 |
Why?
|
| Nicotinic Agonists | 5 | 2015 | 39 | 0.910 |
Why?
|
| Brain | 9 | 2020 | 1485 | 0.910 |
Why?
|
| State Government | 3 | 2018 | 28 | 0.840 |
Why?
|
| Smokers | 4 | 2020 | 114 | 0.840 |
Why?
|
| Law Enforcement | 4 | 2011 | 23 | 0.820 |
Why?
|
| Health Education | 6 | 2008 | 182 | 0.790 |
Why?
|
| Drug and Narcotic Control | 5 | 2011 | 28 | 0.790 |
Why?
|
| Receptors, Nicotinic | 3 | 2020 | 66 | 0.780 |
Why?
|
| Water Pipe Smoking | 5 | 2020 | 9 | 0.780 |
Why?
|
| Family | 3 | 2016 | 229 | 0.770 |
Why?
|
| United States | 31 | 2020 | 7370 | 0.760 |
Why?
|
| Attitude to Health | 5 | 2011 | 279 | 0.680 |
Why?
|
| Plants, Toxic | 6 | 1999 | 13 | 0.670 |
Why?
|
| Young Adult | 15 | 2020 | 4250 | 0.660 |
Why?
|
| Counseling | 6 | 2015 | 349 | 0.650 |
Why?
|
| Child Behavior | 10 | 2010 | 63 | 0.640 |
Why?
|
| Parents | 6 | 2015 | 367 | 0.640 |
Why?
|
| Substance-Related Disorders | 5 | 2020 | 682 | 0.630 |
Why?
|
| Population Surveillance | 2 | 2018 | 194 | 0.620 |
Why?
|
| Government Programs | 1 | 2018 | 20 | 0.610 |
Why?
|
| Motivation | 7 | 2016 | 273 | 0.610 |
Why?
|
| Massachusetts | 19 | 2015 | 2004 | 0.600 |
Why?
|
| Adult | 34 | 2016 | 15615 | 0.590 |
Why?
|
| Health Promotion | 6 | 2018 | 471 | 0.560 |
Why?
|
| Health Surveys | 8 | 2011 | 298 | 0.550 |
Why?
|
| Psychology, Adolescent | 6 | 2009 | 25 | 0.540 |
Why?
|
| Prevalence | 8 | 2016 | 1250 | 0.530 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2015 | 6 | 0.510 |
Why?
|
| Government Regulation | 3 | 2011 | 40 | 0.500 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 20 | 0.500 |
Why?
|
| Receptors, Opioid, mu | 1 | 2015 | 14 | 0.500 |
Why?
|
| Tobacco, Smokeless | 3 | 2011 | 7 | 0.490 |
Why?
|
| Marketing of Health Services | 3 | 2001 | 22 | 0.490 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2010 | 116 | 0.480 |
Why?
|
| Reproducibility of Results | 12 | 2015 | 1558 | 0.480 |
Why?
|
| International Classification of Diseases | 3 | 2010 | 132 | 0.470 |
Why?
|
| Advisory Committees | 1 | 2015 | 108 | 0.470 |
Why?
|
| Parietal Lobe | 1 | 2014 | 27 | 0.450 |
Why?
|
| Behavior Therapy | 1 | 2015 | 161 | 0.450 |
Why?
|
| Asthma | 3 | 2016 | 452 | 0.440 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 55 | 0.440 |
Why?
|
| Longitudinal Studies | 10 | 2020 | 1189 | 0.430 |
Why?
|
| Time Factors | 13 | 2018 | 3586 | 0.430 |
Why?
|
| Cross-Sectional Studies | 9 | 2016 | 2368 | 0.420 |
Why?
|
| Schools | 9 | 2020 | 150 | 0.390 |
Why?
|
| Pediatrics | 3 | 2015 | 240 | 0.390 |
Why?
|
| Inhalation Exposure | 1 | 2012 | 53 | 0.390 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2012 | 34 | 0.380 |
Why?
|
| Risk Factors | 14 | 2015 | 4948 | 0.380 |
Why?
|
| Habits | 1 | 2011 | 20 | 0.370 |
Why?
|
| Age Factors | 9 | 2014 | 1499 | 0.370 |
Why?
|
| Disease Progression | 2 | 2016 | 1120 | 0.370 |
Why?
|
| Benzazepines | 1 | 2011 | 21 | 0.370 |
Why?
|
| Maze Learning | 1 | 2011 | 50 | 0.360 |
Why?
|
| Drug Tolerance | 2 | 2011 | 29 | 0.360 |
Why?
|
| Child Welfare | 3 | 2008 | 52 | 0.360 |
Why?
|
| Impulsive Behavior | 1 | 2011 | 28 | 0.360 |
Why?
|
| Quinoxalines | 1 | 2011 | 35 | 0.360 |
Why?
|
| Mental Recall | 3 | 2014 | 88 | 0.350 |
Why?
|
| Guideline Adherence | 3 | 2009 | 288 | 0.340 |
Why?
|
| Primary Health Care | 1 | 2015 | 643 | 0.330 |
Why?
|
| Prospective Studies | 13 | 2016 | 3052 | 0.320 |
Why?
|
| New Zealand | 4 | 2016 | 37 | 0.320 |
Why?
|
| Psychological Theory | 2 | 2015 | 25 | 0.320 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2009 | 33 | 0.320 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 379 | 0.310 |
Why?
|
| Motor Activity | 1 | 2011 | 333 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2017 | 575 | 0.300 |
Why?
|
| Motion Pictures | 1 | 2007 | 11 | 0.290 |
Why?
|
| Health Behavior | 1 | 2010 | 451 | 0.280 |
Why?
|
| Social Control, Formal | 3 | 2001 | 19 | 0.280 |
Why?
|
| Ganglionic Stimulants | 1 | 2007 | 6 | 0.280 |
Why?
|
| Universities | 1 | 2008 | 144 | 0.270 |
Why?
|
| Personality Inventory | 1 | 2006 | 54 | 0.260 |
Why?
|
| Marketing | 3 | 2014 | 19 | 0.260 |
Why?
|
| Middle Aged | 12 | 2016 | 16240 | 0.260 |
Why?
|
| Physician's Role | 4 | 2003 | 120 | 0.260 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 117 | 0.250 |
Why?
|
| Tobacco Use Cessation | 2 | 2008 | 29 | 0.250 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 150 | 0.250 |
Why?
|
| Odds Ratio | 7 | 2011 | 736 | 0.240 |
Why?
|
| Receptors, Cholinergic | 1 | 2005 | 19 | 0.240 |
Why?
|
| Menthol | 2 | 2017 | 5 | 0.240 |
Why?
|
| Manifest Anxiety Scale | 1 | 2004 | 2 | 0.230 |
Why?
|
| Peer Group | 3 | 2011 | 95 | 0.230 |
Why?
|
| Models, Neurological | 1 | 2005 | 79 | 0.230 |
Why?
|
| Taxes | 3 | 2000 | 6 | 0.230 |
Why?
|
| Social Class | 2 | 2014 | 122 | 0.230 |
Why?
|
| Rats | 5 | 2017 | 1910 | 0.230 |
Why?
|
| Self-Assessment | 1 | 2004 | 58 | 0.230 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 46 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 2055 | 0.230 |
Why?
|
| Nurse's Role | 2 | 2011 | 116 | 0.230 |
Why?
|
| Cyprus | 2 | 2016 | 2 | 0.220 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 1476 | 0.220 |
Why?
|
| Income | 2 | 2003 | 156 | 0.220 |
Why?
|
| Locomotion | 3 | 2017 | 111 | 0.210 |
Why?
|
| Risk Assessment | 6 | 2014 | 1898 | 0.210 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 84 | 0.210 |
Why?
|
| Cues | 3 | 2015 | 73 | 0.210 |
Why?
|
| Adolescent Medicine | 1 | 2003 | 6 | 0.210 |
Why?
|
| Social Environment | 3 | 2015 | 91 | 0.210 |
Why?
|
| Injections, Subcutaneous | 2 | 2015 | 69 | 0.210 |
Why?
|
| Seasons | 1 | 2003 | 123 | 0.210 |
Why?
|
| Pleasure | 2 | 2014 | 13 | 0.210 |
Why?
|
| Proportional Hazards Models | 3 | 2010 | 670 | 0.210 |
Why?
|
| Arousal | 2 | 2014 | 41 | 0.200 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 741 | 0.200 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 283 | 0.200 |
Why?
|
| Lebanon | 5 | 2020 | 10 | 0.200 |
Why?
|
| Factor Analysis, Statistical | 3 | 2015 | 98 | 0.190 |
Why?
|
| Causality | 2 | 2016 | 57 | 0.190 |
Why?
|
| Cohort Studies | 5 | 2009 | 2367 | 0.180 |
Why?
|
| Anxiety | 1 | 2004 | 387 | 0.180 |
Why?
|
| Brain Mapping | 3 | 2016 | 225 | 0.180 |
Why?
|
| Child, Preschool | 3 | 2016 | 1779 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2044 | 0.180 |
Why?
|
| Facility Regulation and Control | 1 | 2000 | 3 | 0.180 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2000 | 7 | 0.180 |
Why?
|
| Industry | 3 | 1996 | 59 | 0.180 |
Why?
|
| Logistic Models | 5 | 2016 | 1223 | 0.180 |
Why?
|
| Sudden Infant Death | 2 | 2004 | 22 | 0.170 |
Why?
|
| Incidence | 3 | 2009 | 1226 | 0.170 |
Why?
|
| Age Distribution | 3 | 2015 | 248 | 0.170 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 16 | 0.170 |
Why?
|
| Marijuana Use | 1 | 2020 | 18 | 0.170 |
Why?
|
| Aged | 7 | 2016 | 13348 | 0.170 |
Why?
|
| Cluster Analysis | 2 | 2016 | 241 | 0.170 |
Why?
|
| Interviews as Topic | 3 | 2007 | 481 | 0.170 |
Why?
|
| Private Sector | 1 | 1999 | 12 | 0.170 |
Why?
|
| Australia | 2 | 2010 | 86 | 0.170 |
Why?
|
| Vaping | 1 | 2020 | 43 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2018 | 6030 | 0.160 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 71 | 0.160 |
Why?
|
| Health Care Costs | 1 | 2001 | 203 | 0.160 |
Why?
|
| Infant | 4 | 2012 | 1482 | 0.160 |
Why?
|
| Research Design | 2 | 2015 | 555 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 156 | 0.160 |
Why?
|
| Colorado | 1 | 2018 | 19 | 0.160 |
Why?
|
| Age of Onset | 2 | 2008 | 170 | 0.150 |
Why?
|
| Quebec | 2 | 2009 | 12 | 0.140 |
Why?
|
| Sex Distribution | 2 | 2008 | 242 | 0.140 |
Why?
|
| Perception | 2 | 2009 | 167 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 2330 | 0.140 |
Why?
|
| Neural Pathways | 2 | 2016 | 95 | 0.140 |
Why?
|
| Brain Chemistry | 1 | 2017 | 77 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 416 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 1090 | 0.140 |
Why?
|
| Public Policy | 2 | 1999 | 37 | 0.140 |
Why?
|
| Public Health | 2 | 2003 | 174 | 0.130 |
Why?
|
| Visual Cortex | 1 | 2016 | 27 | 0.130 |
Why?
|
| Animals | 8 | 2017 | 19589 | 0.130 |
Why?
|
| Tobacco, Waterpipe | 1 | 2016 | 8 | 0.130 |
Why?
|
| Mississippi | 2 | 2015 | 16 | 0.130 |
Why?
|
| Relaxation | 2 | 2007 | 6 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 896 | 0.130 |
Why?
|
| Legislation as Topic | 3 | 1996 | 12 | 0.130 |
Why?
|
| Corpus Striatum | 1 | 2016 | 93 | 0.130 |
Why?
|
| Minisatellite Repeats | 1 | 2015 | 6 | 0.130 |
Why?
|
| Alleles | 2 | 2015 | 410 | 0.130 |
Why?
|
| Regression Analysis | 2 | 2010 | 485 | 0.120 |
Why?
|
| Stress, Psychological | 3 | 2011 | 442 | 0.120 |
Why?
|
| Binge Drinking | 1 | 2016 | 27 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 402 | 0.120 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 48 | 0.120 |
Why?
|
| Genotype | 2 | 2015 | 617 | 0.120 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 288 | 0.120 |
Why?
|
| Sex Factors | 3 | 2007 | 934 | 0.120 |
Why?
|
| Restaurants | 2 | 2018 | 12 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 185 | 0.120 |
Why?
|
| Legislation, Drug | 1 | 2014 | 17 | 0.120 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 452 | 0.110 |
Why?
|
| Communication | 2 | 2015 | 546 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 438 | 0.110 |
Why?
|
| Corpus Callosum | 1 | 2013 | 40 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 2013 | 64 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 806 | 0.100 |
Why?
|
| Netherlands | 1 | 2012 | 22 | 0.100 |
Why?
|
| Ethics, Pharmacy | 1 | 1992 | 3 | 0.100 |
Why?
|
| Academies and Institutes | 1 | 1992 | 21 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 652 | 0.100 |
Why?
|
| Depression | 3 | 2016 | 827 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 1022 | 0.100 |
Why?
|
| Cartoons as Topic | 1 | 1991 | 1 | 0.100 |
Why?
|
| Pharmacies | 1 | 1992 | 34 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2012 | 1281 | 0.100 |
Why?
|
| Prisons | 1 | 2012 | 105 | 0.090 |
Why?
|
| Indians, North American | 1 | 2011 | 27 | 0.090 |
Why?
|
| School Nursing | 1 | 2011 | 26 | 0.090 |
Why?
|
| Reference Values | 2 | 2011 | 326 | 0.090 |
Why?
|
| Florida | 1 | 2011 | 40 | 0.090 |
Why?
|
| Data Collection | 2 | 2005 | 371 | 0.090 |
Why?
|
| Varenicline | 1 | 2011 | 11 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 86 | 0.090 |
Why?
|
| Greece | 1 | 2010 | 3 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2012 | 169 | 0.090 |
Why?
|
| Bias | 2 | 2002 | 106 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 155 | 0.090 |
Why?
|
| Otitis Media | 2 | 2004 | 10 | 0.090 |
Why?
|
| Exploratory Behavior | 2 | 2008 | 33 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2011 | 162 | 0.090 |
Why?
|
| United Kingdom | 1 | 2010 | 69 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 1995 | 364 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2011 | 223 | 0.090 |
Why?
|
| Trust | 1 | 2011 | 67 | 0.090 |
Why?
|
| Manuals as Topic | 1 | 2009 | 8 | 0.080 |
Why?
|
| Research | 1 | 2011 | 188 | 0.080 |
Why?
|
| Physicians, Family | 2 | 2003 | 75 | 0.080 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2009 | 8 | 0.080 |
Why?
|
| New South Wales | 1 | 2009 | 2 | 0.080 |
Why?
|
| Linear Models | 2 | 2011 | 400 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2011 | 5227 | 0.080 |
Why?
|
| Imagination | 1 | 2008 | 7 | 0.080 |
Why?
|
| Personality Assessment | 1 | 2008 | 28 | 0.080 |
Why?
|
| Truth Disclosure | 1 | 2008 | 56 | 0.070 |
Why?
|
| Practice Management, Medical | 1 | 2008 | 20 | 0.070 |
Why?
|
| Internet | 1 | 2011 | 448 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 57 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 165 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 205 | 0.070 |
Why?
|
| Cotinine | 1 | 2007 | 19 | 0.070 |
Why?
|
| Life Style | 1 | 2009 | 299 | 0.070 |
Why?
|
| Rats, Inbred WKY | 2 | 2017 | 11 | 0.070 |
Why?
|
| Psychological Tests | 1 | 2007 | 45 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 157 | 0.070 |
Why?
|
| Endorphins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Nonprescription Drugs | 1 | 2007 | 17 | 0.070 |
Why?
|
| Mass Media | 2 | 2006 | 31 | 0.070 |
Why?
|
| Saliva | 1 | 2007 | 99 | 0.070 |
Why?
|
| Intention | 1 | 2007 | 64 | 0.070 |
Why?
|
| Needs Assessment | 1 | 2008 | 187 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2007 | 146 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2008 | 134 | 0.070 |
Why?
|
| Alcoholism | 1 | 1990 | 308 | 0.070 |
Why?
|
| Narcotics | 1 | 2007 | 50 | 0.070 |
Why?
|
| Serotonin | 1 | 2007 | 59 | 0.070 |
Why?
|
| Risk | 1 | 2007 | 364 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2007 | 98 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2007 | 95 | 0.070 |
Why?
|
| Dopamine | 1 | 2007 | 102 | 0.060 |
Why?
|
| Consensus | 1 | 2007 | 193 | 0.060 |
Why?
|
| Attitude | 2 | 2003 | 96 | 0.060 |
Why?
|
| Financing, Organized | 1 | 2005 | 16 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2006 | 189 | 0.060 |
Why?
|
| Accidents, Traffic | 1 | 1986 | 148 | 0.060 |
Why?
|
| Receptors, Muscarinic | 1 | 2005 | 14 | 0.060 |
Why?
|
| Internal-External Control | 1 | 2005 | 31 | 0.060 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2004 | 10 | 0.060 |
Why?
|
| Hospitalization | 1 | 2012 | 1288 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 1 | 2004 | 19 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2011 | 471 | 0.060 |
Why?
|
| Recurrence | 1 | 2006 | 599 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1021 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 723 | 0.060 |
Why?
|
| Homeostasis | 1 | 2007 | 346 | 0.060 |
Why?
|
| Dizziness | 1 | 2004 | 16 | 0.060 |
Why?
|
| Intelligence | 1 | 2004 | 55 | 0.050 |
Why?
|
| Nursing Methodology Research | 1 | 2003 | 53 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2003 | 42 | 0.050 |
Why?
|
| Texas | 1 | 2003 | 54 | 0.050 |
Why?
|
| Pregnancy | 2 | 2004 | 2202 | 0.050 |
Why?
|
| Nausea | 1 | 2004 | 110 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 395 | 0.050 |
Why?
|
| Personality | 1 | 2003 | 25 | 0.050 |
Why?
|
| Self Report | 2 | 2016 | 359 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2003 | 158 | 0.050 |
Why?
|
| Interview, Psychological | 1 | 2002 | 73 | 0.050 |
Why?
|
| Politics | 1 | 2002 | 32 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2002 | 77 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 264 | 0.050 |
Why?
|
| Models, Econometric | 1 | 2001 | 14 | 0.050 |
Why?
|
| Smoking Water Pipes | 1 | 2020 | 6 | 0.040 |
Why?
|
| Management Audit | 1 | 2000 | 3 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2001 | 216 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2000 | 43 | 0.040 |
Why?
|
| Crime | 1 | 2000 | 50 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2008 | 587 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 297 | 0.040 |
Why?
|
| Chewing Gum | 2 | 2007 | 8 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 582 | 0.040 |
Why?
|
| Rats, Inbred SHR | 1 | 2016 | 5 | 0.030 |
Why?
|
| Adenoidectomy | 1 | 1996 | 4 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 1996 | 8 | 0.030 |
Why?
|
| Middle Ear Ventilation | 1 | 1996 | 4 | 0.030 |
Why?
|
| Fires | 1 | 1996 | 12 | 0.030 |
Why?
|
| Bronchitis | 1 | 1996 | 27 | 0.030 |
Why?
|
| Self Concept | 1 | 2016 | 105 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 34 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 52 | 0.030 |
Why?
|
| Office Visits | 1 | 1996 | 39 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 91 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1995 | 94 | 0.030 |
Why?
|
| Fetal Death | 1 | 1995 | 12 | 0.030 |
Why?
|
| Infant Mortality | 1 | 1995 | 19 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 1995 | 29 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1995 | 56 | 0.030 |
Why?
|
| Health Policy | 1 | 1996 | 175 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 1996 | 208 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 145 | 0.030 |
Why?
|
| Cough | 1 | 1996 | 182 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1077 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 58 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1996 | 228 | 0.030 |
Why?
|
| Pneumonia | 1 | 1996 | 279 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 69 | 0.030 |
Why?
|
| Pattern Recognition, Visual | 1 | 1991 | 37 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 241 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 1992 | 210 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 349 | 0.020 |
Why?
|
| Decision Making | 1 | 1992 | 394 | 0.020 |
Why?
|
| Role Playing | 1 | 1988 | 7 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2008 | 32 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 26 | 0.020 |
Why?
|
| Tablets | 1 | 2007 | 16 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1990 | 1048 | 0.020 |
Why?
|
| Ethanol | 1 | 1990 | 306 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 215 | 0.020 |
Why?
|
| Oxygen | 1 | 2008 | 313 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2A6 | 1 | 2004 | 1 | 0.010 |
Why?
|
| Social Behavior | 1 | 2005 | 87 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2005 | 194 | 0.010 |
Why?
|
| Health Planning Guidelines | 1 | 2003 | 31 | 0.010 |
Why?
|
| Organizational Policy | 1 | 2003 | 47 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2002 | 33 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 169 | 0.010 |
Why?
|
| Family Practice | 1 | 2003 | 207 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 673 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 440 | 0.010 |
Why?
|
| Focus Groups | 1 | 2002 | 287 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 441 | 0.010 |
Why?
|
| Emotions | 1 | 2002 | 214 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 700 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 5101 | 0.010 |
Why?
|